Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000950170-24-012394

Options or other derivatives

  • Chief Financial Officer acquired 371,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Moran Kyle · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-05 Grant or award : show line 1 in the form Share Option (right to buy) +371,500 371,500 D
Loading xslF345X05/ownership.xml…